Whilst maternal probiotic supplementation resulted in higher breast milk concentrations of TLSP at 10  days postpartum, this does not appear to be a mechanism for prevention of AD by maternal probiotics. < /p > < p class= " a-plus-plus " > < em class= " a-plus-plus " > Trial registration < /em > The original trial protocol is registered in Clinica..."> Whilst maternal probiotic supplementation resulted in higher breast milk concentrations of TLSP at 10  days postpartum, this does not appear to be a mechanism for prevention of AD by maternal probiotics. < /p > < p class= " a-plus-plus " > < em class= " a-plus-plus " > Trial registration < /em > The original trial protocol is registered in Clinica..." /> Whilst maternal probiotic supplementation resulted in higher breast milk concentrations of TLSP at 10  days postpartum, this does not appear to be a mechanism for prevention of AD by maternal probiotics. < /p > < p class= " a-plus-plus " > < em class= " a-plus-plus " > Trial registration < /em > The original trial protocol is registered in Clinica..." />

Atopic dermatitis prevention in children following maternal probiotic supplementation does not appear to be mediated by breast milk TSLP or TGF- β

Conclusions < /h3 > < p class= " a-plus-plus " > Whilst maternal probiotic supplementation resulted in higher breast milk concentrations of TLSP at 10  days postpartum, this does not appear to be a mechanism for prevention of AD by maternal probiotics. < /p > < p class= " a-plus-plus " > < em class= " a-plus-plus " > Trial registration < /em > The original trial protocol is registered in ClinicalTrials.gov (identifier NCT00159523) < /p > < /span >
Source: Clinical and Translational Allergy - Category: Allergy & Immunology Source Type: research